Managing residual risk in patients receiving statin therapy.
Where this comes from
- Record sourced from PubMed, PMID 20367579.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Until the results of several statin trials are available, it is recommended that the current indications and usage of ezetimibe be continued.